[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 1977

Human Chorionic Gonadotropin (HCG) Treatment of Obesity

Author Affiliations

From the Endocrine-Metabolic Section, Department of Medicine, Milwaukee County Medical Complex, and Wood Veterans Administration Center, the Medical College of Wisconsin, and Deaconess Hospital, Milwaukee.

Arch Intern Med. 1977;137(2):151-155. doi:10.1001/archinte.1977.03630140007005
Abstract

After a nine-day control period, six hospitalized obese women were placed on 500 calorie diets and were given 125 IU of human chorionic gonadotropin (HCG) intramuscularly daily for 30 days. Another five obese women received injections of diluent only and consumed identical diets for the same period. Mean weight loss in the HCG-treated group was nearly identical to that achieved by women given the placebo. Reduction of triceps skinfold thickness or circumferential body measurements of the chest, waist, hips, and thighs were not different. Patterns of change of a variety of plasma and urine substrates, electrolytes, and hormones were similar in the two groups and consistent with semistarvation and weight loss. These results indicate that HCG has no effects on chemical and hormonal parameters measured and offers no advantage over calorie restriction in promoting weight loss.

(Arch Intern Med 137:151-155, 1977)

×